CAS: 899796-83-9 - Milatuzumab
Fórmula:Unspecified
- Sinónimos:
- hLL 1
- Immunoglobulin G1, anti-(human class II antigen invariant chain) (human-mouse monoclonal hLL1 heavy chain), disulfide with human-mouse monoclonal hLL1 κ-chain, dimer
- IMMU 115
- Immunoglobulin G1, anti-(human CD74 antigen) (human-mouse monoclonal hLL1 heavy chain), disulfide with human-mouse monoclonal hLL1 κ-chain, dimer
- Milatuzumab
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Milatuzumab REF: TM-T77478CAS: 899796-83-9 | 95% - SDS-PAGE:95% SEC-HPLC:99.99% | 269,00 €~1.100,00 € | Mar 15 Oct 24 |
 | Milatuzumab REF: 3D-CLA1109CAS: 899796-83-9 | - - - | A consultar | Vie 25 Oct 24 |
Milatuzumab
CAS:899796-83-9
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74.
Pureza:
95% - SDS-PAGE:95% SEC-HPLC:99.99%
Forma y color:
Solid
Ref: TM-T77478
| 1mg | 269,00 € | ||
| 5mg | 701,00 € | ||
| 10mg | 1.100,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Octubre de 2024
Ref: 3D-CLA1109
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 25 de Octubre de 2024
